首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2458527篇
  免费   204073篇
  国内免费   4525篇
耳鼻咽喉   35358篇
儿科学   75028篇
妇产科学   64379篇
基础医学   346071篇
口腔科学   69289篇
临床医学   224647篇
内科学   486262篇
皮肤病学   49353篇
神经病学   209206篇
特种医学   99022篇
外国民族医学   889篇
外科学   372403篇
综合类   57789篇
现状与发展   2篇
一般理论   1128篇
预防医学   198943篇
眼科学   57591篇
药学   183704篇
  6篇
中国医学   4505篇
肿瘤学   131550篇
  2018年   25821篇
  2017年   20023篇
  2016年   21895篇
  2015年   24923篇
  2014年   35871篇
  2013年   54676篇
  2012年   74024篇
  2011年   78008篇
  2010年   45806篇
  2009年   44054篇
  2008年   74343篇
  2007年   78988篇
  2006年   79885篇
  2005年   78156篇
  2004年   75132篇
  2003年   72855篇
  2002年   71695篇
  2001年   113318篇
  2000年   117218篇
  1999年   99251篇
  1998年   29106篇
  1997年   26529篇
  1996年   26271篇
  1995年   25401篇
  1994年   23846篇
  1993年   22222篇
  1992年   79924篇
  1991年   76870篇
  1990年   74071篇
  1989年   71286篇
  1988年   66265篇
  1987年   65200篇
  1986年   61739篇
  1985年   58885篇
  1984年   44843篇
  1983年   38237篇
  1982年   23736篇
  1981年   21150篇
  1980年   19741篇
  1979年   41634篇
  1978年   29423篇
  1977年   24750篇
  1976年   23180篇
  1975年   24282篇
  1974年   29923篇
  1973年   28285篇
  1972年   26396篇
  1971年   24255篇
  1970年   22863篇
  1969年   21177篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
41.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
42.
43.
44.
45.
46.
47.
48.
Acne vulgaris (acne) is a chronic inflammatory disease of the sebaceous gland, characterized by follicular hyperkeratinization, excessive colonization by Propionibacterium acnes (Pacnes) as well as immune reactions and inflammation. Despite an armamentarium of topical treatments available including benzoyl peroxide, retinoids and azelaic acid, topical antibiotics in monotherapies, especially erythromycin and clindamycin, are still used in Europe to treat acne. This intensive use led to antimicrobial‐resistant P. acnes and staphylococci strains becoming one of the main health issues worldwide. This is an update on the current topical acne treatments available in Europe, their mechanism of action, their potential to induce antimicrobial resistance and their clinical efficacy and safety.  相似文献   
49.
50.
Dosage form is a mean used for the delivery of drug to a living body. In order to get the desired effect the drug should be delivered to its site of action at such rate and concentration to achieve the maximum therapeutic effect and minimum adverse effect. Since oral route is still widely accepted route but having a common drawback of difficulty in swallowing of tablets and capsules. Therefore a lot of research has been done on novel drug delivery systems. This review is about oral dispersible tablets a novel approach in drug delivery systems that are now a day''s more focused in formulation world, and laid a new path that, helped the patients to build their compliance level with the therapy, also reduced the cost and ease the administration especially in case of pediatrics and geriatrics. Quick absorption, rapid onset of action and reduction in drug loss properties are the basic advantages of this dosage form.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号